XERS   $5.44  -2.51% Market Closed After Close 5.7 4.78%

Xeris Biopharma Holdings, Inc.

EMA (20): 2026-01-28 the price crossed down the moving average line and demonstrates a strong downside trend.

EMA (50): 2026-01-28 the price crossed down the moving average line and demonstrates a strong downside trend.

EMA (100): 2026-02-03 the price crossed down the moving average line and demonstrates a strong downside trend.

RSI: RSI indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: exit from the overbought zone.

MACD: Oscillator MACD is in the negative territory it's lower than the signal line and falls. These factors mean that negative mood prevails. Last signal: signal line crossed the middle level.

Stochastic: The stochastic indicator is in the oversold territory and it falls. These factors indicate that the downside potential still holds even though the market is oversold. Last signal: entry into the oversold zone.

Trend Type up and flat
Power medium strength
Trend Pattern
EMA (20) Signals bearish reversal
EMA (20) Yield -15.92%
EMA (20) date of signal Jan. 28, 2026, 3 a.m.
EMA (50) Signals bearish reversal
EMA (50) Yield -15.92%
EMA (50) date of signal Jan. 28, 2026, 3 a.m.
EMA (100) Signals bearish reversal
EMA (100) Yield -17.98%
EMA (100) date of signal Feb. 3, 2026, 3 a.m.
RSI Signals bullish reversal
RSI (14) Yield 0.0
RSI (14) date of signal March 4, 2026, 3 a.m.
MACD Signals bearish recovery
MACD Yield -1.63%
MACD date of signal Feb. 27, 2026, 3 a.m.
Stochastic Signals bearish
Stochastic Yield 1.35%
Stochastic date of signal March 3, 2026, 3 a.m.
Updated March 4, 2026, 9 p.m.